Product Name | Oridonin |
Description |
HSP70 inhibitor & NLRP inflammasome inhibitor |
Purity | >98% (TLC); NMR (Conforms) |
CAS No. | 28957-04-2 |
Molecular Formula | C20H28O6 |
Molecular Weight | 364.4 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inhibitor |
Solubility | May be dissolved in DMSO (50 mg/ml); or Ethanol (10 mg/ml, warm) |
Source | Synthetic |
Appearance | White to off-white powder |
SMILES | CC1(CCC(C23C1C(C(C45C2CCC(C4O)C(=C)C5=O)(OC3)O)O)O)C |
InChI | InChI=1S/C20H28O6/c1-9-10-4-5-11-18-8-26-20(25,19(11,14(9)22)15(10)23)16(24)13(18)17(2,3)7-6-12(18)21/h10-13,15-16,21,23-25H,1,4-8H2,2-3H3/t10-,11-,12-,13+,15+,16-,18+,19-,20+/m0/s1 |
InChIKey | SDHTXBWLVGWJFT-XKCURVIJSA-N |
Safety Phrases | Classification: Warning. Hazard Statements: H351. Precautionary Statements: P203, P280, P318, P405, and P501 |
Cite This Product | Oridonin (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-624) |
Alternative Names | 7a,20-Epoxy-1a,6b,7,14-tetrahydroxykaur-16-en-15-one; Isodonol |
Research Areas | Apoptosis, Cancer, Stem Cells |
PubChem ID | 5321010 |
Scientific Background | A potent, covalent inhibitor of the NLRP3 inflammasome with anti-inflammatory activity in various mouse models (1). Inhibits vascular inflammation in vivo (2). Inhibits aberrant AKT activation in human breast cancer cells with hyperactivated PI3K/AKT signaling (3). Inhibits migration, invasion and adhesion of melanoma cells (4). Induces apoptosis in osteosarcoma cells by multiple pathways (5). |
References |
1. He H., et al. (2018) Nat. Commun. 9:2550. 2. Huang W., et al. (2018) Eur. J. Pharmacol. 826:133. 3. Sun B., et al. (2018) Oncotarget 9:23878. 4. Li CY., et al. (2018) Oncol. Lett. 15:1362. 5. Lu Y., et al. (2018) Cell Death Dis. 9:15. |
Reviews
There are no reviews yet.